Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01780701 · ClinicalTrials.gov registry record
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- 66
- Enrollment target
NCT01780701: Completed study, sponsored by OHSU Knight Cancer Institute.
NCT01780701 is a clinical trial that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01780701 has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
A prostate cancer diagnosis starts a list of events that often leads to fast-moving treatment, thought by many to result in vast over-treatment of this disease. So, discovery of different diagnostic methods that allow clinicians to identify slow-growing from potentially fast-growing disease prior to or at the time of prostate biopsy could result in early and suitable treatment for men at greatest risk, while greatly decreasing the number of biopsies, surgical procedures, hormonal and chemotherapeutic treatments, cost, and patient worry, for those with more slow-growing disease.
Primary Outcome
Determine the correlation between the amount of intraprostatic lipid using 1H (proton) magnetic resonance spectroscopic imaging (MRSI) with an endorectal coil obtained prior to prostatectomy with fatty acid synthase protein expression measured in benign and cancer tissue from prostatectomy samples.
Interventions
- PROCEDURE Magnetic Resonance Spectroscopy Imaging with rectal probe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2013-01 |
| Est. Completion | 2017-03 |
What the finished NCT01780701 record still lists
NCT01780701 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Spectroscopy Imaging with rectal probe is the first listed.
NCT01780701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01780701 about?
NCT01780701 is a clinical study titled "Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer". A prostate cancer diagnosis starts a list of events that often leads to fast-moving treatment, thought by many to result in vast over-treatment of this disease. So, discovery of different diagnostic methods that allow clinicians to identify slow-growing from potentially fast-growing disease prior to...
What is the current status of trial NCT01780701?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2013-01. Estimated completion is 2017-03.
What interventions are being tested in trial NCT01780701?
The interventions under investigation include: Magnetic Resonance Spectroscopy Imaging with rectal probe (PROCEDURE).
Who is sponsoring clinical trial NCT01780701?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia